Vanda Pharmaceuticals (VNDA) Finished Goods (2014 - 2018)

Vanda Pharmaceuticals (VNDA) has 5 years of Finished Goods data on file, last reported at $1.0 million in Q1 2018.

• For the quarter ending Q1 2018, Finished Goods rose 31.98% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2018 stood at $1.0 million (up 31.98% YoY), and the FY2017 full-year result was $760000.0, changed 0.26% from the prior year.
• Finished Goods rose to $1.0 million in Q1 2018, from $760000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $3.4 million in Q4 2014 to a low of $611000.0 in Q2 2017.
• A 5-year average of $1.5 million and a median of $941000.0 in 2014 frame the typical range for Finished Goods.
• Peak annual rise in Finished Goods reached 181.19% in 2015, while the deepest fall reached 61.87% in 2015.
• Tracing VNDA's Finished Goods over 5 years: stood at $3.4 million in 2014, then sank by 61.87% to $1.3 million in 2015, then slumped by 41.11% to $762000.0 in 2016, then retreated by 0.26% to $760000.0 in 2017, then jumped by 33.03% to $1.0 million in 2018.
• Business Quant data shows VNDA's Finished Goods at $1.0 million in Q1 2018, $760000.0 in Q4 2017, and $858000.0 in Q3 2017.